AMGN (AMGN) Stock Price & Analysis
AMGN (AMGN) fell 1.55% to USD 437.23 as of September 8, 2026 at 02:51 UTC, according to Nexqual real-time market data.
AMGN last closed at USD 437.23; the session ranged USD 435.01–441.66 on volume of 1,656,089 shares. Market capitalization is —, with a 52-week range of USD 269.77–447.03 (NMS). Source: Nexqual, September 8, 2026 at 02:51 UTC.
Key Statistics (as of September 8, 2026 at 02:51 UTC)
| Price | USD 437.23 |
|---|---|
| Change | ▼ 1.55% (down) |
| Previous Close | USD 437.23 |
| Open | USD 437.23 |
| Day Range | USD 435.01 – 441.66 |
| 52-Week Range | USD 269.77 – 447.03 |
| Volume | 1,656,089 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (AMGN)
Nexqual's technical model rates AMGN "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 02:51 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 63.74 (neutral) |
| vs SMA50 | Above (USD 397.06) |
| MACD | 12.74 (positive) |
From AMGN's Latest SEC 10-K Filing (filed 2026-02-13)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIIB | Biogen Inc. | USD 220.83 | ▼ 0.83% |
| GILD | Gilead Sciences, Inc. | USD 151 | ▲ 0.93% |
| BMY | Bristol-Myers Squibb Company | USD 66.82 | ▼ 1.24% |
| MRK | Merck & Company, Inc. | USD 150.33 | ▼ 0.86% |
| LLY | Eli Lilly and Company | USD 1,149.36 | ▼ 0.92% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 02:51 UTC. This page is informational and not investment advice.